Intratumoral adoptive transfer of inflammatory macrophages engineered by co-activating TLR and STING signaling pathways exhibits robust antitumor activity
This study demonstrated that engineered inflammatory macrophages have potential as an effective ACT for treating solid tumors.
Source: Clinical and Experimental Medicine - Category: Research Source Type: research
More News: Cancer & Oncology | Genetics | Hematology | Insect Bites & Stings | Melanoma | Research | Skin Cancer | Study